MedTrace Logo

Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes

NCT07704320 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-07-15

No results posted yet for this study

Summary

A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BreathAlert, a low cost battery-powered monitor that detects and corrects apnea. This study evaluates the ability of BreathAlert to detect respiration and apneic episodes in infants. Data from BreathAlert and vital signs monitors is collected. The performance of BreathAlert in respiration and apnea detection is compared with traditional vital sign monitoring which may include temperature, heart rate, EKG, respiratory rate, SPO2 and impedance pneumography.

Conditions

  • Apnea Infant

Interventions

DEVICE

BreathAlert (low cost respiratory rate and apnea monitor)

A BreathAlert device is attached to the subject. Data from BreathAlert and vital signs monitors is collected.

Sponsors & Collaborators

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • William Marsh Rice University

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-11
Primary Completion
2027-12-31
Completion
2028-06-30

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07704320 on ClinicalTrials.gov